Exelixis, Inc.

EXELNASDAQHealthcare● Active

$52.70

+$0.21(+0.40%)

Market Cap$13.2B

P/E Ratio—

52W High$52.98

52W Low$33.76

Avg Volume2.6M

Open$52.41

Beta0.43

Overview

Exelixis, Inc. (EXEL) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

EXEL · free cash flow · updated Jun 8, 2026

Core FCF metrics

EXEL · FCF · TTM · margin & CAGR

Free cash flow was $844.3M for FY2026 (fiscal year ending 2026-01-02), up 33.2% year-over-year The FCF margin was 36.4%. Five-year CAGR stands at +36.4%.

FY2026 Free Cash Flow$844.3M▲ +33.2% YoY

Trailing 12M (TTM)$916.4Mtrailing 4 quarters sum

FCF Margin36.4%$844.3M ÷ revenue

3-Year CAGR+55.6%FY2023 → FY2026

5-Year CAGR+36.4%FY2021 → FY2026

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

EXEL · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2026Latest$884.3M(40M)$844.3M▲ +33.2%36.4%

FY2025$700.0M(66M)$633.8M▲ +272.0%29.2%

FY2023$333.3M(163M)$170.4M▼ 24.0%9.3%

FY2022$362.6M(138M)$224.2M▼ 33.4%13.9%

FY2021$400.8M(64M)$336.6M▲ +88.4%23.5%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

EXEL · P/FCF · FCF yield · FCF per share

Exelixis, Inc. (EXEL) trades at a FCF yield of 6.92% and a price-to-free-cash-flow ratio of 15.6x. FCF per share stands at $3.37, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

6.92%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$3.37

TTM FCF ÷ Shares Outstanding

Price / FCF

x15.6

Share Price ÷ FCF per Share

EV / FCF (TTM)

x14.4

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2026 · 2026-01-02

Cash flow statement summary

EXEL · cash flow statement · operating / investing / financing

For FY2026, Exelixis, Inc. generated $884.3M in operating cash flow and spent 40M in capital expenditures, yielding $844.3M in free cash flow.

Operating Activities

+$884.3M

Cash from core business operations

2026-01-02

Investing Activities

+$350.4M

CapEx, acquisitions & investments

2026-01-02

Financing Activities

−$969.6M

Buybacks, dividends & debt

2026-01-02

FCF FormulaOperating CF ($884.3M) − |CapEx| (40M) = FCF ($844.3M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

EXEL vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Exelixis, Inc.YOU

EXEL

$844.3M+33.2%36.4%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Exelixis, Inc. (EXEL) reported free cash flow of $844.3M for FY2026 (fiscal year ending 2026-01-02), up 33.2% year-over-year. The FCF margin was 36.4%.

Based on available data, Exelixis, Inc. has maintained positive free cash flow for at least 10 fiscal year(s). FCF peaked at $844.3M in FY2026. The 5-year CAGR stands at +36.4%.

Exelixis, Inc.'s FCF yield is 6.92% and price-to-FCF ratio is 15.6x for FY2026, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

EXEL free cash flow · 8 questions

Exelixis, Inc. free cash flow was $844.3M for FY2026, up 33.2% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $916.4M.

EXEL free cash flowEXEL FCFEXEL FCF 2026EXEL free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Exelixis, Inc. · Exelixis, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026